Analyst Ratings for Auxilium Pharmaceuticals (AUXL) [Neutrals]
AUXL Rating Summary
AUXL Price Target Summary
- Highest: $37.00 (Aegis Capital)
- Lowest: $13.00 (Brean Capital)
- Average: $25.83
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$25.83 (+70.7%)
Avg. $ Target:
$25.83 (+70.7%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/3/2013 | Morgan Stanley | Upgrade | Equalweight (Underweight) |
N/A (N/A) |
14.66 | 15.13 | 3.21% | Details |
| 8/1/2012 | MKM Partners | Downgrade | Neutral (Buy) |
N/A (N/A) |
26.94 | 15.13 | -43.84% | Details |
| 8/1/2012 | Leerink Swann | Downgrade | Market Perform (Outperform) |
27.00 (25.00) |
26.94 | 15.13 | -43.84% | Details |
| 7/6/2010 | Oppenheimer » Updated 6/14/2012 |
Downgrade | Perform (N/A) |
N/A (N/A) |
21.46 | 15.13 | -29.5% | Details |
